2016
DOI: 10.1016/j.nbt.2016.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Thermostable β-galactosidases for the synthesis of human milk oligosaccharides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
44
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 41 publications
(45 citation statements)
references
References 19 publications
1
44
0
Order By: Relevance
“…The reaction yield at 95 °C was three times higher than that obtained at 60 °C (32.01 and 10.58% respectively). Similar effect was observed by Zeuner et al [30] who reported a sixfold increase of the reaction yield (from 0.9 to 5.4%) in the N-acetyllactosamine synthesis catalyzed by βgalactosidase from Pyrococcus furiosus when the temperature was raised from 40 to 90 °C. In another work, the conversion yield of GOS in the presence of β-galactosidase from Bacillus circulans was three times greater at 60 °C than at 25 °C (5 and 15 g/L, respectively) [31].…”
Section: Synthesis Of Fucosylated Oligosaccharidessupporting
confidence: 86%
“…The reaction yield at 95 °C was three times higher than that obtained at 60 °C (32.01 and 10.58% respectively). Similar effect was observed by Zeuner et al [30] who reported a sixfold increase of the reaction yield (from 0.9 to 5.4%) in the N-acetyllactosamine synthesis catalyzed by βgalactosidase from Pyrococcus furiosus when the temperature was raised from 40 to 90 °C. In another work, the conversion yield of GOS in the presence of β-galactosidase from Bacillus circulans was three times greater at 60 °C than at 25 °C (5 and 15 g/L, respectively) [31].…”
Section: Synthesis Of Fucosylated Oligosaccharidessupporting
confidence: 86%
“…Hence, a large incentive for biosynthetic production of authentic HMO structures for use in, for example, infant formulae or as functional food ingredients, exist. Lacto‐ N ‐triose II (LNT2, GlcNAcβ1‐3Galβ1‐4Glc, Scheme ) is a central HMO backbone moiety that is particularly relevant to synthesize not only because of its reported putative prebiotic effects in itself but notably because LNT2 can serve as a backbone precursor for further chain‐elongation reactions in biomimetic HMO production . Biocatalytic synthesis of LNT2 on the basis of the addition of N ‐acetylglucosamine to lactose can be accomplished either by β‐ N ‐acetylglucosaminyltransferases or by transglycosylation catalyzed by the β‐ N ‐acetylhexosaminidases of glycosyl hydrolase family 20 (GH20) .…”
Section: Introductionmentioning
confidence: 99%
“…However, the strongest tool to efficiently improve transglycosylation activity and/or diminish hydrolytic activity in GHs is protein engineering. Enzymatic transglycosylation has shown great potential in HMO synthesis, especially for sialylation or fucosylation of lactose or LNT [42,48,51,52,53,54,55,56,57], but also for synthesis of HMO core structures [58,59,60,61]. This technology holds great potential to expand the current limited industrial-scale HMO portfolio, but much of this potential relies on either the discovery of novel transglycosidases or protein engineering of the enzymes for improved transglycosylation efficiency.…”
Section: Routes To Hmo Production Outside the Mammary Glandmentioning
confidence: 99%
“…Using one of the most efficient commercial β-galactosidase preparations—Biolacta, which contains several Bacillus circulans β-galactosidases [151]—a 19% yield of LNnT was obtained from a reaction with Lac and LNT2 [61] (Table 1). A one-pot cascade reaction from Lac to LNnT was not accomplished due to low LNT2 yields [60]. β-Galactosidase-catalyzed production of LNT from LNT2 has only been reported with a o -nitrophenyl galactoside donor using a GH35 β1,3-galactosidase from B. circulans [61].…”
Section: Abundant Natural Substrates From Dairy and Agro-industriamentioning
confidence: 99%